Iranian Journal of Radiology

Published by: Kowsar

Synchronous Occurrence of Classic and Scirrhous Hepatocellular Carcinomas: A Case Report

Seung Soo Kim 1 , * , Jeong Ah Hwang 1 , Hyeong Cheol Shin 1 , Soon Auck Hong 2 , Sung Shick Jou 1 , Woong Hee Lee 1 , Chan Ho Park 1 and Seo-Youn Choi 3
Authors Information
1 Department of Radiology, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan-si, Korea
2 Department of Pathology, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan-si, Korea
3 Department of Radiology, Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
Article information
  • Iranian Journal of Radiology: October 2018, 15 (4); e65346
  • Published Online: July 3, 2018
  • Article Type: Case Report
  • Received: December 20, 2017
  • Revised: April 10, 2018
  • Accepted: April 17, 2018
  • DOI: 10.5812/iranjradiol.65346

To Cite: Kim S S, Ah Hwang J, Cheol Shin H, Auck Hong S, Shick Jou S, et al. Synchronous Occurrence of Classic and Scirrhous Hepatocellular Carcinomas: A Case Report, Iran J Radiol. 2018 ; 15(4):e65346. doi: 10.5812/iranjradiol.65346.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Bruix J, Sherman M, Practice Guidelines Committee AAFTSOLD. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-36. doi: 10.1002/hep.20933. [PubMed: 16250051].
  • 2. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013;1(5):351-7. doi: 10.1177/2050640613501507. [PubMed: 24917983]. [PubMed Central: PMC4040774].
  • 3. Kurogi M, Nakashima O, Miyaaki H, Fujimoto M, Kojiro M. Clinicopathological study of scirrhous hepatocellular carcinoma. J Gastroenterol Hepatol. 2006;21(9):1470-7. doi: 10.1111/j.1440-1746.2006.04372.x. [PubMed: 16911695].
  • 4. Kim SH, Lim HK, Lee WJ, Choi D, Park CK. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol. 2009;69(1):123-30. doi: 10.1016/j.ejrad.2007.09.008. [PubMed: 17976942].
  • 5. Yamashita Y, Fan ZM, Yamamoto H, Matsukawa T, Arakawa A, Miyazaki T, et al. Sclerosing hepatocellular carcinoma: radiologic findings. Abdom Imaging. 1993;18(4):347-51. [PubMed: 8220034].
  • 6. Chen F, Li HJ, Zhao DW, Feng JL, Ding JL. Rare CT and MR imaging features of scirrhous hepatocellular carcinoma with gross specimen and pathologic correlation: Case report and review of the literature. Radiol Infect Dis. 2015;2(3):137-40. doi: 10.1016/j.jrid.2015.07.003.
  • 7. Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma. J Comput Assist Tomogr. 2013;37(6):872-81. doi: 10.1097/RCT.0b013e31829d44c1. [PubMed: 24270108].
  • 8. Kim SH, Lee WJ, Lim HK, Park CK. Sclerosing hepatic carcinoma: helical CT features. Abdom Imaging. 2007;32(6):725-9. doi: 10.1007/s00261-006-9174-0. [PubMed: 17203330].
  • 9. Omata M, Peters RL, Tatter D. Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver. 1981;1(1):33-49. [PubMed: 6294435].
  • 10. Iha H. Clinicopathological study on scirrhous hepatocellular carcinoma. A study of 12 resected cases. Kanzo. 1994;35(12):855-63. doi: 10.2957/kanzo.35.855.
  • 11. Albar JP, De Miguel F, Esbrit P, Miranda R, Fernandez-Flores A, Sarasa JL. Immunohistochemical detection of parathyroid hormone-related protein in a rare variant of hepatic neoplasm (sclerosing hepatic carcinoma). Human Pathol. 1996;27(7):728-31. doi: 10.1016/s0046-8177(96)90405-0.
  • 12. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273(1):30-50. doi: 10.1148/radiol.14132362. [PubMed: 25247563]. [PubMed Central: PMC4263770].
  • 13. Yoshikawa J, Matsui O, Kadoya M, Gabata T, Arai K, Takashima T. Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr. 1992;16(2):206-11. [PubMed: 1312098].
  • 14. Chong YS, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC, et al. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Clin Radiol. 2012;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. [PubMed: 22425613].
  • 15. Park CI, Park YN. Immunohistochemical profile of sclerosing hepatic carcinoma. Korea J Pathol. 1994;28(6):636-42.
  • 16. Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40(2):298-304. [PubMed: 14739102].
  • 17. Maeda A, Ebata T, Matsunaga K, Kanemoto H, Bando E, Yamaguchi S, et al. Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium. J Hepatobiliary Pancreat Surg. 2005;12(6):484-7. doi: 10.1007/s00534-005-1010-3. [PubMed: 16365824].
  • 18. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol. 1996;149(4):1167-75. [PubMed: 8863666]. [PubMed Central: PMC1865193].
  • 19. Robrechts C, De Vos R, Van den Heuvel M, Van Cutsem E, Van Damme B, Desmet V, et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver. 1998;18(4):288-93. [PubMed: 9766827].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments